This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Melchor, L. Articles by Benítez, J. Search for Related Content PubMed PubMed Citation Articles by Melchor, L. Articles by Benítez, J.

The Accumulation of Specific Amplifications Characterizes Two Different Genomic Pathways of Evolution of Familial Breast Tumors

Authors' Affiliations: ¹ Human Genetics Group; Human Cancer Genetics Programme; ² Cytogenetics Unit, Biotechnology Programme; and ³ Laboratory of Breast and Gynecological Cancer, Molecular Pathology Programme, Spanish National Cancer Center, Madrid, Spain; and ⁴ Department of Genetics, Hospital Santa Creu i Sant Pau, Barcelona, Spain

Requests for reprints: Javier Benítez, Human Genetics Department, Spanish National Cancer Centre CNIO, Calle Melchor Fernandez Almagro 3, Madrid 28029, Spain. Phone: 34-91-224-6965; Fax: 34-91-224-6923; E-mail: jbenitez{at}cnio.es.

Purpose and Methods: High-level DNA amplifications are recurrently found in breast cancer, and some of them are associated with poor patient prognosis. To determine their frequency and co-occurrence in familial breast cancer, we have analyzed 80 tumors previously characterized for BRCA1 and BRCA2 germ-line mutations (26 BRCA1, 18 BRCA2, and 36 non-BRCA1/2) using high-resolution comparative genomic hybridization.

Results: Twenty-one regions were identified as recurrently amplified, such as 8q21-23 (26.25%), 17q22-25 (13.75%), 13q21-31 (12.50%), and 8q24 (11.25%), many of which were altered in each familial breast cancer group. These amplifications defined an amplifier phenotype that is correlated with a higher genomic instability. Based on these amplifications, two different genomic pathways have been established in association with 8q21-23 and/or 17q22-25 and with 13q21-31 amplification. These pathways are associated with specific genomic regions of amplification, carry specific immunohistochemical characteristics coincident with high and low aggressiveness, and have a trend to be associated with BRCA1 and BRCA2/X, respectively.

Conclusion: In summary, our data suggest the existence of two different patterns of evolution, probably common to familial and sporadic breast tumors.

This article has been cited by other articles:

				M. Shehata, I. Bieche, R. Boutros, J. Weidenhofer, S. Fanayan, L. Spalding, N. Zeps, K. Byth, R. K. Bright, R. Lidereau, et al. Nonredundant Functions for Tumor Protein D52-Like Proteins Support Specific Targeting of TPD52 Clin. Cancer Res., August 15, 2008; 14(16): 5050 - 5060. [Abstract] [Full Text] [PDF]

				L. Melchor, E. Honrado, J. Huang, S. Alvarez, T. L. Naylor, M. J. Garcia, A. Osorio, D. Blesa, M. R. Stratton, B. L. Weber, et al. Estrogen Receptor Status Could Modulate the Genomic Pattern in Familial and Sporadic Breast Cancer Clin. Cancer Res., December 15, 2007; 13(24): 7305 - 7313. [Abstract] [Full Text] [PDF]